Elyse Olesinski | Profiles RNS

Elyse A. Olesinski, MPH

MD Student

Boston University Chobanian & Avedisian School of Medicine

Pronouns: she/her/hers

Websites

	LinkedIn
	Spectrum of Physician Advocacy Student Group
	BU Mentoring for Aspiring Physician Students
	Student Oncology Society
	ORCID

ORCID : 0000-0002-2717-9755

Publications
Honors

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Olesinski EA, Bergenholtz S, Datar Y, Hirsch AE. Society of General Internal Medicine Annual Meeting. Assessment of a Novel Program Highlighting Student Stories in Pre-Clinical Medical Curriculum at an Academic Institution. 2024. View Publication

Olesinski EA, Bhatia KS, Wang C, Pioso MS, Lin XX, Mamdouh AM, Ng SX, Sandhu V, Jasdanwala SS, Yilma B, Bohl S, Ryan JA, Malani D, Luskin MR, Kallioniemi O, Porkka K, Adamia S, Chng WJ, Osato M, Weinstock DM, Garcia JS, Letai A, Bhatt S. Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood Cancer Discov. 2024 May 01; 5(3):180-201. PMID: 38442309

Felong T, Bakhtyari A, Olesinski E, Lenio S, Marks A. 10th Annual Carlos S. Kase Boston University Neurology Research Symposium. A Case of Steroid-Responsive Cerebral Amyloid Angiopathy-Related Inflammation. 2024.
Olesinski E, Bhatia K, Wang C, Pioso M, Ng SX, Lin XX, Sandhu V, Yilma B, Bohl SRM, Ryan J, Malani D, Luskin MR, Kallioniemi O, Porkka K, Yeoh A, Adamia S, Chng WJ, Osato M, Weinstock DM, Garcia JS, Letai AG, Bhatt S. American Society of Hematology (ASH) Conference. Targeting Mitochondrial Apoptotic Priming State to Personalize Therapy for Relapsed Acute Myeloid Leukemia. 2023. View Publication
Zhang X, Olesinski EA, Duong Q, Truong MT, Lee S, Jang S, Mak KS, Parekh A, Hirsch AE. . International Journal of Radiation Oncology. Development and Assessment of a Multi-Purpose Knowledge-Based Planning Model (RapidPlan) for Prostate Radiation. 2023. View Publication

Olesinski EA, Bhatia KS, Mahesh AN, Rosli S, Mohamed JS, Jen WY, Jain N, Garcia JS, Wong GC, Ooi M, Letai A, Konopleva M, Bhatt S. BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia. Blood Adv. 2023 Jun 27; 7(12):2917-2923. PMID: 36763538; PMCID: PMC10285538; DOI: 10.1182/bloodadvances.2022007728;

Olesinski EA, Zhang X, Duong Q, Hirsch AE. American Society of Clinical Oncology. Validation of a newly-developed knowledge-based model for prostate cancer radiotherapy. 2024.
Olesinski EA, Bergenholtz S, Datar Y, Hirsch A. 18th Annual McCahan Education Conference. Implementation and assessment of a novel program to highlight student stories in the BUMC pre-clinical curriculum. 2024. View Publication

Valentine SE, Fuchs C, Olesinski EA, Sarkisova N, Godfrey LB, Elwy AR. Formative evaluation prior to implementation of a brief treatment for posttraumatic stress disorder in primary care. Implement Sci Commun. 2023 May 04; 4(1):48.View Related Profiles.

Elwy, A. Rani
Fuchs, Cara
Olesinski, Elyse
Valentine, Sarah

PMID: 37143109; PMCID: PMC10161536; DOI: 10.1186/s43058-023-00426-2;

Olesinski EA, Bhatia KS, Pioso MS, Weinstock D, Garcia J, Letai A, Bhatt S. American Medical Association Research Challenge. A New Achille’s Heel: Targeting Reduced Mitochondrial Apoptotic Signaling in Relapsed Acute Myeloid Leukemia. 2022.

Showing 10 of 18 results. Show More

Bhatia K, Mahesh A, Olesinski E, Garcia J, Jain N, Jen WY, Ming MOG, Letai A, Konopleva M, Bhatt S. Proceedings of the European Hematology Association 2022 Hybrid Congress. BH3 profiling identifies selective BCL-2 dependence of adult early T-cell progenitor and typical acute lymphoblastic leukemia patients. 2022.
Sarah Valentine, Cara Fuchs, Natalya Sarkisova, Elyse Olesinski, A. Rani Elwy. International Society for Traumatic Stress Studies. Formative evaluation to identify the need for intervention ?augmentation and system alignment prior to implementation of ?a brief tratment for PTSD in safety net primary care. 2021. View Publication

Olesinski EA, Bhatt S. Dynamic BH3 profiling method for rapid identification of active therapy in BH3 mimetics resistant xenograft mouse models. STAR Protoc. 2021 06 18; 2(2):100461. PMID: 34027474; PMCID: PMC8131978; DOI: 10.1016/j.xpro.2021.100461;

Bhatt S, Piosos MS, Olesinski EA, Yilma BG, Ryan JA, Mashaka T, Leutz B, Adamia S, Weinstock DM, Garcia JS, Letai A. Proceedings of the American Association for Cancer Research Annual Meeting 2021. Reduction in mitochondrial priming drives resistance to targeted therapy in acute myeloid leukemia. 2021.

Bhatt S, Pioso MS, Olesinski EA, Yilma B, Ryan JA, Mashaka T, Leutz B, Adamia S, Zhu H, Kuang Y, Mogili A, Louissaint A, Bohl SR, Kim AS, Mehta AK, Sanghavi S, Wang Y, Morris E, Halilovic E, Paweletz CP, Weinstock DM, Garcia JS, Letai A. Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia. Cancer Cell. 2020 12 14; 38(6):872-890.e6. PMID: 33217342; PMCID: PMC7988687; DOI: 10.1016/j.ccell.2020.10.010;

Bhatt S, Pioso M, Olesinski EA, Yilma B, Buon L, Adamia S, Zhu H, Ryan J, Wang Y, Erick M, Halilovic E, Weinstock DM, Garcia JS, Letai A. Individualized Mitochondrial Functional Approach to Combination of BCL-2 and MCL-1 Antagonism in Acute Myeloid Leukemia. American Society of Hematology. 2019.

Sperling AS, Burgess M, Keshishian H, Gasser JA, Bhatt S, Jan M, Slabicki M, Sellar RS, Fink EC, Miller PG, Liddicoat BJ, Sievers QL, Sharma R, Adams DN, Olesinski EA, Fulciniti M, Udeshi ND, Kuhn E, Letai A, Munshi NC, Carr SA, Ebert BL. Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs. Blood. 2019 07 11; 134(2):160-170.View Related Profiles.

Olesinski, Elyse
Munshi, Nikhil C.

PMID: 31043423; PMCID: PMC6624968; DOI: 10.1182/blood.2019000789;

Bhatt S, Yilma B, Olesinski E, Zhu H, Murakami M, Murali VM, Adamia S, Weinstock DM, Garcia JS, Letai A. Proceedings of the American Association for Cancer Research Annual Meeting 2019. Individualized functional approach to tailoring acute myeloid leukemia therapy. 2019.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 18 publications over 6 distinct years, with a maximum of 6 publications in 2023

Bar chart showing 18 publications over 6 distinct years, with a maximum of 6 publications in 2023

Year	Publications
2019	3
2020	1
2021	3
2022	2
2023	6
2024	3

2023 Boston University School of Medicine: Serchuck Award

2022 Karin Grunebaum Cancer Research Foundation: Karin Grunebaum Summer Research Fellowship

2022 Boston University School of Medicine: Medical Student Summer Research Program

2020 Boston University School of Public Health: Practicum Scholar Award

2018 Boston University: Yawkey Foundation Nonprofit Internship Program

Contact for Mentoring:

Olesinski's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (30) concept(s)

Co-Authors

See all (4) people

Similar People

See all (60) people